Trade policy volatility and supply chain governance

BANI framework illustrating trade policy volatility and supply chain governance in pharmaceutical supply chains.

Recent developments in U.S. trade policy are introducing another layer of volatility into global supply chains.

The announcement of a 10–15% tariff under Section 122, combined with a 150-day tariff horizon, creates a policy instrument that is immediate in effect but uncertain in duration.

At the same time, legal questions and institutional responses add further complexity.

For highly regulated sectors such as pharmaceutical logistics, these developments interact with already constrained supply networks and long regulatory timelines.

Even where direct tariff exposure remains limited, system effects can become visible quickly:
• cost shocks in lean networks
• disrupted planning cycles
• supplier rigidity due to validation requirements
• increased compliance complexity

These dynamics illustrate how trade policy shifts can propagate through complex logistics networks, particularly in highly regulated sectors with limited structural flexibility.